← All peptidesBlends
Sermorelin + Ipamorelin
Sermorelin + Ipamorelin
GHRH analog plus ghrelin agonist studied for synergistic GH release, sleep, and body-recomposition endpoints.
Typical dose
200–300 mcg
Frequency
Pre-bed daily
Half-life
—
Route
subcutaneous
Typical vial sizes
10 mg
Sample reconstitution
10 mg vial · 2 mL bac water · 250 mcg dose
- Draw volume
- 0.050 mL
- Insulin units
- 5 units
- Concentration
- 5.00 mg/mL
- Doses per vial
- 40.0
Research notes
As sold: Sermorelin 5mg + Ipamorelin 5mg (1:1). ~200-300mcg of each pre-bed to align with natural GH pulses.
Further reading
- Published research on Sermorelin + Ipamorelin (PubMed) →
- Clinical trials for Sermorelin + Ipamorelin (ClinicalTrials.gov) →
Links open live searches on authoritative databases — verify dosing and safety against primary sources.
Research use only.
Information on this page is a reference log compiled from public sources and is not medical advice. Consult a licensed physician before making any decisions about your health.